BIOGEN IDEC INC. 4
4 · BIOGEN IDEC INC. · Filed Jun 1, 2007
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
GLASSBERG ALAN
Director
Transactions
- Sale
Common Stock
2007-05-30$51.54/sh−20,000$1,030,800→ 1,250 total - Award
Stock Option (right to buy)
2007-05-31+5,950→ 5,950 totalExercise: $52.22Exp: 2017-05-30→ Common Stock (5,950 underlying) - Award
Common Stock
2007-05-31+2,300→ 3,550 total - Exercise/Conversion
Stock Option (right to buy)
2007-05-30−20,000→ 10,000 totalExercise: $31.08From: 2001-01-03Exp: 2010-01-02→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2007-05-30$31.08/sh+20,000$621,666→ 21,250 total
Footnotes (4)
- [F1]Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Restricted Stock Units were granted as an award for no consideration. Each Restricted Stock Unit represents the right to receive one share of BIIB common stock.
- [F3]Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
- [F4]Options will become 100% exercisable upon completion of one year of service with Biogen Idec Inc.